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Available online xxxxBackground: Although the descending aortic diameter is larger in smokers, data about thoracic aortic growth is
missing. Our aim is to present the distribution of thoracic aortic growth in smokers and to compare it with liter-
ature of the general population.
Methods: Current and ex-smokers aged 50–70 years from the longitudinal Danish Lung Cancer Screening Trial,
were included. Mean and 95th percentile of annual aortic growth of the ascending aortic (AA) and descending
aortic (DA) diameters were calculated with the ﬁrst and last non-contrast computed tomography scans during
follow-up. Determinants of change in aortic diameter over time were investigated with linear mixed models.
Results: A total of 1987 participants (56% male, mean age 57.4 ± 4.8 years) were included. During a median
follow-up of 48months, mean AA and DA growth rates were comparable between males (AA 0.12± 0.31 mm/-
year and DA 0.10 ± 0.30 mm/year) and females (AA 0.11 ± 0.29 mm/year and DA 0.13 ± 0.27 mm/year). The
95th percentile ranged from 0.42 to 0.47 mm/year, depending on sex and location. Aortic growth was compara-
ble between current and ex-smokers and aortic growthwas not associatedwith pack-years. Ourﬁndings are con-
sistent with aortic growth rates of 0.08 to 0.17 mm/years in the general population. Larger aortic growth was
associated with lower age, increased height, absence of medication for hypertension or hypercholesterolemia
and lower Agatston scores.
Conclusions: This longitudinal study of smokers in the age range of 50–70 years shows that ascending and de-
scending aortic growth is approximately 0.1 mm/year and is consistent with growth in the general population.
© 2019 Elsevier B.V. All rights reserved.Keywords:
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‘Dilatation of the thoracic aorta is associatedwith an increased risk of
aortic dissection [1], with high mortality rates of up to 50% in the ﬁrst
30 days [2]. In addition to the absolute diameter, fast growth of 3–
5 mm/year is mentioned in the guidelines on the diagnosis and treat-
ment of aortic diseases as an important risk factor for dissection and is435, DoctorMolewaterplein 40,
elink).
eliability and freedom from bias
Gamechi, C.G.E. Thijssen, et a
urnal of Cardiology, https://dtherefore an additional indication to perform preventive surgery [3,4].
However, data about risk factors for fast aortic growth is scarce. It has
been shown that patients with a bicuspid aortic valve or Marfan syn-
drome show larger aortic growth rates than the general population
[5]. Smoking is associatedwith larger diameter of the aortic arch andde-
scending aorta [6–8] and with larger aortic growth of the abdominal
aorta [9]. Whether smoking is associated with faster thoracic aortic
growth is still unknown.With use of a large prospective longitudinal co-
hort study, the Danish Lung Cancer Screening Trial (DLCST), we aimed
to investigate whether aortic growth is larger in current or former
smokers when compared to the available cross-sectional studies of the
general population. With our longitudinal data of the thoracic aortic
growth we will also be able to identify risk factors for fast growth in
this subgroup of the population.’l., Growth of the thoracic aorta in the smoking population: The Danish
oi.org/10.1016/j.ijcard.2019.06.010
Fig. 1. Measurements of the average ascending and descending aortic diameter. A 3D
image of the automatic tool which extracts the centerline (blue) and the surface of the
aorta (red) to compute the ascending (AA) and descending aortic (DA) diameters at the
level of pulmonary artery bifurcation. Cross-sectional views of the ascending and
descending aorta are shown left (AA) and right (DA). Both cross-sections are overlaid
with the automatically extracted aortic area (in red). The average diameters is
computed as Diameter ¼ 2 ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃArea=πp . (For interpretation of the references to color in this
ﬁgure legend, the reader is referred to the web version of this article.)
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2.1. Study population
Participants were recruited from DLCST (www.ClinicalTrials.gov, registration num-
ber: NCT 00496977), a randomized controlled trial conducted between 2004 and 2010.
Participants in the DLCST volunteered in response to local media advertisements. Current
and former smokers aged 50–70 years with at least 20 pack-years and forced expiratory
volume in ﬁrst second (FEV 1) of N30% of predicted value were included. Participants
with body weight above 130 kg, previous treatment for any kind of cancer within
5 years, tuberculosis within 2 years, and any serious illness with life expectancy
b10 yearswere excluded. The primary aimof this RCTwas to investigate the effect of com-
puted tomography screening on lung cancermortality. No statistically signiﬁcant effects of
CT screening on lung cancer mortality were found. The study was approved by the Na-
tional Ethics Committee of Denmark (identiﬁcation no. H-KA-02045, supplementary pro-
tocol 20148) and all participants gave written informed consent. The study design is
explained in more detail before [10].
In the DLCST study 2052 participants were randomized to the screening group, which
received annualmultidetector computed tomography (MDCT) during a 5 year period. This
MDCT scans provided the opportunity to perform a post-hoc analysis in which the aortic
growth was measured over a long period. For this study we excluded participants with
b1-year follow-up between theﬁrst and last CT scans (n=65), because this follow-up pe-
riodwas too short to accuratelymeasure growth. Overall, 1987 participantswere included
in the current study.
Clinical characteristics regarding smoking status, history of stroke and ischemic heart
disease, medical treatment for diabetes, hypertension or hypercholesterolemia and
Agatston calcium scores (of the ascending aorta + arch and of the descending aorta)
were collected at baseline as previously deﬁned and described [11]. The Agatston calcium
score is a measure of arterial calcium on computed tomography. The calculation is based
on the weighted density score given to the highest attenuation value (HU) multiplied by
the volume of the calciﬁcation. The Agatston score of the ascending aorta, aortic arch
and descending aorta were assessed by one observer using Vitrea v. 6.0 (Vital Images,
Inc., MN, USA). A standardized procedure for calcium scoring with a threshold of 130
Hounsﬁeld units (HU) was used to identify aortic calciﬁcations.
2.2. Computed tomography imaging
All non-ECG-gated, non-contrast CT scans were performed in a single institution with
a 16-row Philips Mx8000 MDCT scanner, Philips Medical Systems, Eindhoven, the
Netherlands. Scanswere performed in supine position after full inspiration in caudocranial
scan direction including the entire rib cage and upper abdomenwith 120 kV and 40mAs.
Scans were performedwith spiral data acquisition with the following parameters: section
collimation, 16 × 0.75 mm; pitch, 1.5; and rotation time of 0.5 s. The obtained data were
reconstructed with a slice thickness of 1mm and a hard reconstruction algorithm (Philips
D kernel).
2.3. Measurements of aortic diameter
Aortic diametersweremeasuredwith use of an automaticmethod, which is validated
in 100 participants showing a good agreement with manual aortic diameter measure-
ments [12]. Themethod combinesmulti atlas registration to obtain seed points, aorta cen-
terline extraction, and an optimal surface segmentation approach [13] to extract the aorta
surface around the centerline. From the extracted 3D aorta segmentation, the average di-
ameters of the ascending aorta and descending aorta at the level of the pulmonary artery
bifurcation were computed from the cross-sectional area measured at cross-sectional
slices perpendicular to the extracted centerline (Fig. 1). The aortic wall with possible cal-
ciﬁcation was included in the measurements. In 29 participants, an error occurred in the
automatic method for centerline extraction and therefore no aortic diameters were auto-
matically computed. The ascending and descending aortic diameters for these cases were
measuredmanually by drawing the centerline and cross-sectional vessel contour perpen-
dicular to the centerline at the pulmonary bifurcation level as described in detail in our
previous work [12]. In the remaining 1958 subjects with accurate centerline extraction
we visually checked the following cases to identify inadequate measurements as a results
of the automatic method: (1) all outliers of the aortic diameter at baseline and follow-up
deﬁned as 2.7 standard deviation above or beneath the median; (2) all subjects who
showed aortic growth or decline of N3.5 mm; and (3) a random sample of 200 images
(100 baseline and 100 follow-up scans in the same subjects). From the randomly selected
200 scans, only 3 (1.5%) at the ascending aorta and 4 (2%) at the descending aorta showed
a slight over or under segmentation. Overall, in 68 subjects adequatemeasurements of the
automaticmethodwere not available due to inadequate segmentations. Also the aortic di-
ameters for these 68 cases weremeasuredmanually for both the ascending and descend-
ing aorta diameter. As a result, ascending and descending aortic diameters and aortic
growth was available in all 1987 participants.
2.4. Statistical analysis
Data are expressed as mean ± SD or as median ± interquartile range in case the dis-
tribution was not normal. Data distribution was checked using histograms. Categorical
variables are presented as frequencies with percentages. To present the distribution of an-
nual aortic growth, the annual growth rate was calculated by subtracting the aortic diam-
etermeasured on the baseline CT scan from the aortic diametermeasured on the last scanPlease cite this article as: L.R. Bons, Z. Sedghi Gamechi, C.G.E. Thijssen, et a
Lung Cancer Screening Trial, International Journal of Cardiology, https://dduring follow-up and subsequently dividing this value by the number of years between
the baseline and last follow-up scan. The Student's t-test or Mann-Whitney test was
used to compare means between two groups at baseline. Comparison of categorical vari-
ables was done using the Chi-square test or the Fisher's exact test. For the analyses of
Agatston scores, we used natural log-transformed values and added 1.0 mm3 to the
nontransformed Agatston values (Ln(calciﬁcation volume + 1)) to deal with values of
zero. For pack-years we used the log-transformed values.
To investigate whether change in aortic diameter was associated with baseline char-
acteristics, linear mixed effects (LME) models were used. The ascending and descending
aortic diameter were consecutively used as the dependent variable. Time was entered as
a random effect. First, all baseline variables were entered concomitantly as independent
variables to identifywhether theywere independently associatedwith the aortic diameter
(while taking into account that the aortic diameter was measured twice in each partici-
pant by using the LME). All baseline characteristics (i.e. age, height, weight, sex, medical
treatment, medical history, pack years, Agatston scores) were deemed clinically relevant
based on previous research [7,8,14]. Second, interaction terms of each of the baseline var-
iableswith timewere entered consecutively into themultivariablemodel, to assess the in-
dependent effect of each of these variables on the change of aortic diameter over time.We
also examined the interaction term between time and large aortic diameter (ascending
aorta N40 mm and descending aorta N30 mm) to assess whether participants with larger
aortic diameters show larger changes in aortic diameter over time. All interaction terms,
that were found to be signiﬁcant were presented in the ﬁgures. We checked whether
the assumptions underlying linear mixed effects modelling (linearity and homoscedastic-
ity) were satisﬁed.
The IBM SPSS® statistics 21.0 software was used to analyze the data and a p-value of
b0.05 was considered signiﬁcant.
3. Results
3.1. Study population
The baseline characteristics of the 1987 included participants are
presented in Table 1 for the total group and separately for males and fe-
males. The mean age of our cohort was 57.4 ± 4.8 years. Antihyperten-
sive medication was used by 14.8% of the participants.
3.2. Aortic diameters and aortic growth
The distribution of the aortic diameters for both males and females
can be found in Supplemental Fig. 1. The ascending and descending aor-
tic diameter at baseline were signiﬁcantly larger in males (ascending
aorta 36.0 ± 3.5 mm and descending aorta 28.2 ± 2.2 mm) than inl., Growth of the thoracic aorta in the smoking population: The Danish
oi.org/10.1016/j.ijcard.2019.06.010
3L.R. Bons et al. / International Journal of Cardiology xxx (xxxx) xxxfemales (ascending aorta 33.6 ± 3.2 mm and descending aorta 26.1 ±
2.2 mm). A baseline aortic diameter of ≥40 mm at the ascending aorta
was found in 167 (8%) participants. For the descending aorta, a baseline
aortic diameter of ≥40mmwas found in 1 (0%) participant and ≥30mm
in 257 (13%) participants. The distribution of annual aortic growth for
both males and females is shown in Fig. 2 and was calculated during a
median follow-up of 48 months (IQR 47–50 months). Annual growth
did not statistically signiﬁcantly differ between males and females for
the ascending aorta (males 0.12 ± 0.31 mm/year and females 0.11 ±
0.29 mm/year) and descending aorta (males 0.10 ± 0.30 mm/year
and females 0.13 ± 0.27 mm/year). In addition, the aortic growth did
not differ signiﬁcantly between current or former smokers for the as-
cending aorta (current 0.12 ± 0.30 mm/year and former 0.13 ±
0.29 mm/year) and descending aorta (current 0.11 ± 0.30 mm/year
and former 0.11 ± 0.25 mm/year). In total, 621 (31%) participants
showed decrease of the ascending aortic diameter in time and 604
(30%) of the descending aortic diameter. Eighteen people (1%) had an
aortic growth of N1 mm/year, which in 9 persons only occurred in the
ascending aorta (2 former and 7 current smoker), in 6 persons only in
the descending aorta (all current smokers) and in 3 persons in both
the ascending and descending aorta (one former and two current
smokers). In two people (0.1%) N2 mm/year (both descending aorta)
was found and only one (0.05%) showed N3 mm/year.3.3. Determinants of aortic growth
The association between the baseline characteristics and the aortic
diameter is shown in Supplemental Table 1. Higher age, larger height
and weight, hypertension and higher Agatston scores were associated
with larger ascending aortic diameters, while female and diabetes
were associated with smaller ascending aortic diameters. For the de-
scending aorta, higher age, height, weight and Agatston scores were as-
sociated with larger aortic diameters, while female and
hypercholesterolemia were associated with smaller aortic diameters.
Fig. 3 shows the signiﬁcance of the interaction terms between base-
line variables and time from the linear mixed effects models. Larger
height was associated with larger increase in aortic diameter over
time. Higher age, hypertension, hypercholesterolemia and Agatston
scores were associated with smaller increase in ascending aortic diam-
eter over time. For the descending aorta, higher age, hypertension and
higher Agatston score of the descending aorta were associated with
smaller change of the descending aorta over time.Table 1
Baseline characteristics.
Total (n =
1987)
Age, years 57.4 ± 4.8
Height, cm 173.8 ± 8.8
Weight, kg 76.5 ± 14.2
Medical treatment
Hypertension, N (%) 294 (14.8%)
Hypercholesterolemia, N (%) 168 (8.5%)
Diabetes, N (%) 39 (2.0%)
History of stroke, N (%) 34 (1.7%)
History of ischemic heart disease, N (%) 40 (2.0%)
Current smoking, N (%) 491 (24.7%)
Pack-yearsa 34 (27–42.5)
Agatston score ascending aorta + archa 36 (0–273)
Agatston score descending aortaa 0 (0–38)
Baseline ascending aortic diameter 35 ± 4
Baseline descending aortic diameter 27 ± 2
Values are presented asmean (SD) ormedian (IQR) for continuous variables and N (%) for dicho
and Agatston scores of the aorta (n = 8, 0.4%).
a Nontransformed median score with interquartile range.
b Mann-Whitney test.
c Fisher's exact test.
Please cite this article as: L.R. Bons, Z. Sedghi Gamechi, C.G.E. Thijssen, et a
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This is the ﬁrst study presenting longitudinal data on sex-speciﬁc
growth of the ascending and descending aorta in a large population of
current or former smokers with at least 20 pack-years. Males showed
a growth of 0.12 ± 0.31 mm/year for the ascending aorta and 0.10 ±
0.30 mm/year for the descending aorta. In females, we found a growth
of 0.11 ± 0.29 mm/year for the ascending aorta and 0.13 ± 0.27 mm/-
year for the descending aorta. Previous studies showed that smoking
is associated with larger diameter of the aortic arch or descending
aorta [6–8], suggesting faster growth. As such, it would be expected
that the descending aortic growth will also be faster in our study com-
pared to the general population. Nevertheless, our study showed com-
parable or even smaller growth rates compared to the two largest
cross-sectional cohort studies who reported on the association between
age and descending aortic diameter. Kalsch et al. [15] calculated an in-
crease of 0.17 mm for males and 0.16 for females per 1 year increase
in age. Wolak et al. [8] showed that the descending aortic diameter
was 0.13 mm larger each 1 year increase in age, which is comparable
to our results. Only one study, the Framingham Heart Study [14], mea-
sured the thoracic aortic growth longitudinally in a healthy population,
but they solelymeasured the growth at the level of the aortic root. In ad-
dition, we have also found no association between pack years and de-
scending aortic growth. Therefore, we can conclude that our data do
not support the hypothesis that descending aortic growth would be
larger in current or former smokers compared to the general popula-
tion. Since there is no association found previously between the ascend-
ing aortic diameter and smoking, we did not expect any effect of
smoking on the ascending aortic growth, which was also conﬁrmed by
our results.
The conclusions must be interpreted with caution taking into ac-
count the measurement variability of non-ECG-gated non-enhanced
CT. In previous literature, the mean intra-observer variation between
two measurements of the ascending aorta found in contrast CT scans
is found to be 0.1–0.3 mm for manual measurements [16–18]. Possibly
for non-contrast CT scans it is larger. The decrease in AA and DA diam-
eter in 31% and 30% of the participants, respectively, is in part caused
by thismeasurement variability. However, the absolutemeandifference
between the ﬁrst and last CT scan, not divided by the amount of years in
between the two scans,was 0.46±1.05mm for the ascending aorta and
0.44 ± 0.97 mm for the descending aorta. This is higher than we would
expect based on the intra-observer variability of 0.1–0.3mm and there-
for our change in aortic diameter could not only be explained byMales (n =
1111)
Females (n
= 876)
p-Value
57.8 ± 4.8 56.9 ± 4.8 b0.001
179.4 ± 6.3 166.7 ± 6.0 b0.001
83.2 ± 12.1 68.0 ± 12.0 b0.001
158 (14.2%) 136 (15.5%) 0.416
109 (9.8%) 59 (6.7%) 0.014
30 (2.7%) 9 (1.0%) 0.008
24 (2.2%) 10 (1.1%) 0.082
36 (3.2%) 4 (0.5%) b0.001
274 (24.7%) 217 (24.8%) 0.955c
36 (29–46) 31 (25.5–39) b0.001b
33 (0–247) 39.5 (0–303.8) 0.795b
0 (0–45) 0 (0–25) 0.005b
36 ± 3 34 ± 3 b0.001
28 ± 2 26 ± 2 b0.001
tomous variables. Missing valueswere present for age (n= 1, 0.0%), weight (n= 2, 0.0%)
l., Growth of the thoracic aorta in the smoking population: The Danish
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Fig. 2. Annual growth of the ascending and descending aorta. Lighter bars represent decrease in diameter and darker bars represent increase in diameter. No differences were found
between males and females in ascending aortic growth (p = 0.394) and descending aortic growth (p = 0.087).
4 L.R. Bons et al. / International Journal of Cardiology xxx (xxxx) xxxmeasurement variability. Moreover, the use of identical CT scanners and
automated segmentation for both baseline and follow-up measure-
ments is an important strength of this study because it prevented us
from additional inter-observer and inter-modality variability.
4.1. Determinants of aortic growth
From previous literature we know that body measurements are im-
portant in the assessment of aortic diameters [19,20]. For instance, in
Turner patients with typically a short stature, the use of the aortic size
index (ASI) is advised, which corrects for body surface area [21]. For
the aortic growth, little data is available on the effect of body measure-
ments. The Framingham Heart Study [14] included a slightly younger
population (mean age 50 ± 14 years) with comparable BMI (25.5 ±
4.4 kg/m2) and showed that BMI was correlated with change in aortic
root diameter over time. We examined height and weight separately
and showed that the effect of body measures on the ascending aortic
growth is mainly based on height.
Higher age was associated with both less ascending and descending
aortic growth. Aortic remodeling over the adult life is accompanied by
reduced aortic elasticity [22] and reduced tortuositywith increased cur-
vature [23]. Because of these changes, one may expect aortic growth
will decrease at older age and aortic diameters will stabilize. Treatment
for hypertension was associatedwith slower ascending and descending
aortic growth. Since higher blood pressure is associated with larger de-
scending aortic diameters [7], we would assume that participants with
hypertension would show larger descending aortic growth. However,
patients being treated for hypertension may represent the group with
controlled blood pressure and the group of patients who are not receiv-
ing treatment may contain patients with uncontrolled blood pressure.
Because we had no information about the exact blood pressure, which
is a limitation of this study, we could not verify this assumption. This
could also be the case with hypercholesterolemia because patientsPlease cite this article as: L.R. Bons, Z. Sedghi Gamechi, C.G.E. Thijssen, et a
Lung Cancer Screening Trial, International Journal of Cardiology, https://dwith treatment for hypercholesterolemia showed a smaller increase in
aortic diameter. An ascending aortic diameter of N40mmor descending
aortic diameter of N30mmwas not associated with change in diameter
over time in our cohort. Although patients with aortic aneurysms show
larger growth rates [24], we may have had too few patients with aortic
dilatation in our cohort to prove this.
A recent systematic review, which included all causes of thoracic
aortic aneurysms, showed a mean growth rate in patients from 0.2 to
2.8 mm/year for ascending aorta and aortic arch, while those for de-
scending and aorta ranged from 1.9 to 3.4 mm/year [24]. Detaint et al.
[5] observed at the level of the ascending aorta an aortic growth of
0.12 ± 1.0 mm/year in Marfan syndrome and 0.42 ± 0.6 mm/year in
BAV. These growth rates of patients with a bicuspid aortic valve or de-
generative aortapathy are larger than found in our cohort with current
and ex-smokers. In current guidelines for thoracic aortic diseases, differ-
ent deﬁnitions are used for extensive growth (≥3mmor ≥5mm), which
warrants preventive surgery. Our study showed only two cases with
growth N2 mm/year and only one with N3 mm/year, which suggests
that extensive growth, deﬁned by the guidelines, is relatively rare in
the general smoking population. Based on our 95th percentiles, annual
aortic growth of 0.5 mm is the upper limit of normal in current or for-
mer smokers.
4.2. Limitations
One large limitation of our study is that we did not include our
own reference group of healthy subjects. The literature only
contained cross-sectional data with the mean thoracic aortic
growth rate of the general population and therefore we could
not compare the distribution (95th percentile) of aortic growth
rates in our group with a reference group. Another limitation is
the lack of information about diseases related to aortic pathology,
such as connective tissue disease and bicuspid aortic valve. Thisl., Growth of the thoracic aorta in the smoking population: The Danish
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Fig. 3.Mixedmodels including interaction terms between baseline variable and time in years. All models were adjusted for sex, age, height, weight, hypertension, hypercholesterolemia,
diabetes, history of stroke, history of ischemic heart disease, pack-years, Agatston score of the ascending aorta and aortic arch and the Agatston score of the descending aorta. The
continuous variables age and height were dichotomized at their median value. Age, height and Agatston scores were added as continuous variable in the interaction terms.
*Interpretation: A higher age is associated with less increase in the ascending aortic diameter over time (in years).
5L.R. Bons et al. / International Journal of Cardiology xxx (xxxx) xxxinformation was not available because the primary aim of this RCT
was to investigate the effect of computed tomography screening
on lung cancer mortality. Because this study was a post-hoc anal-
ysis, thoracic aortic growth was neither a primary nor a secondary
outcome measure of the original trial. The limited age range of
50–70 years also prevents the generalization of our results to
the total population. In addition, the limited aortic growth may
have limited the power of our analysis. However, our cohort was
large enough to ﬁnd a signiﬁcant aortic growth for both the as-
cending and descending aorta and also several determinants
were found to be signiﬁcant associated with the change in tho-
racic aortic diameter over time. Another limitation of this study
is the use of non-ECG gated, non-contrast CT scans. Non-gated
CT scans show signiﬁcant more motion artifacts than ECG-gated
CT scans [25], which likely effect aortic measurements. The use
of contrast-enhanced CT is preferred for thoracic aortic measure-
ments but could cause unnecessary complications. However,
both baseline and follow-up measurements were made in the
same manner.
An issue that warrants consideration in our study is the fact that
we examined a total of 13 variables. If we were to account forPlease cite this article as: L.R. Bons, Z. Sedghi Gamechi, C.G.E. Thijssen, et a
Lung Cancer Screening Trial, International Journal of Cardiology, https://dmultiple testing using a Bonferroni correction, only age would re-
main statistically signiﬁcant for the ascending aorta, while hyper-
tension and Agatston score would remain statistically signiﬁcant
for the descending aorta. However, our study was not data driven
but hypothesis driven; the choice of variables we investigated was
based on previous ﬁndings from the literature. These variables
were thus already implicated in the disease process by earlier stud-
ies. Correcting for multiple testing in spite of this hypothesis driven
approach could result in failure to recognize potentially interesting
factors. In any case, our ﬁndings may be considered as indicative of a
potential association, and these hypothesis generating ﬁndings
merit validation in other large studies.
5. Conclusion
This longitudinal study of current and ex-smokers shows that the as-
cending and descending aorta grows on average 0.1 mm/year in both
males and females in the age range of 50–70 years. The aortic growth
rates are consistent (or even smaller) with the numbers available in
cross-sectional studies of the general population. According to the
95th percentile, an aortic growth of N0.5 mm/year can be consideredl., Growth of the thoracic aorta in the smoking population: The Danish
oi.org/10.1016/j.ijcard.2019.06.010
6 L.R. Bons et al. / International Journal of Cardiology xxx (xxxx) xxxthe upper limit of normal. Larger change of aortic diameters in timewas
associated with lower age, increased height, absence of medication for
hypertension or hypercholesterolemia, lower Agatston score and a
large thoracic aortic diameter.
Supplementary data to this article can be found online at https://doi.
org/10.1016/j.ijcard.2019.06.010.
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